OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 80 filers reported holding OYSTER PT PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $61,000 | -86.6% | 10,834 | -72.4% | 0.00% | – |
| Q1 2022 | $456,000 | -32.1% | 39,209 | +6.7% | 0.00% | – |
| Q4 2021 | $672,000 | +57.0% | 36,761 | +1.6% | 0.00% | – |
| Q3 2021 | $428,000 | -26.5% | 36,192 | +6.9% | 0.00% | – |
| Q2 2021 | $582,000 | +51.2% | 33,861 | +61.0% | 0.00% | – |
| Q1 2021 | $385,000 | -11.3% | 21,027 | -8.7% | 0.00% | – |
| Q4 2020 | $434,000 | -5.4% | 23,028 | +5.8% | 0.00% | – |
| Q3 2020 | $459,000 | -16.4% | 21,756 | +14.4% | 0.00% | – |
| Q2 2020 | $549,000 | -21.9% | 19,020 | -5.2% | 0.00% | – |
| Q1 2020 | $703,000 | +173.5% | 20,072 | +91.1% | 0.00% | – |
| Q4 2019 | $257,000 | – | 10,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |